Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 18180321)

Published in J Endocrinol on January 01, 2008

Authors

Raquel Moral1, Richard Wang, Irma H Russo, Coral A Lamartiniere, Julia Pereira, Jose Russo

Author Affiliations

1: Breast Cancer Research Laboratory, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, USA.

Articles citing this

Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12

Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect (2008) 3.27

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 2.51

Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol (2011) 2.28

In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect (2010) 1.75

Neonatal exposure to bisphenol a alters reproductive parameters and gonadotropin releasing hormone signaling in female rats. Environ Health Perspect (2009) 1.21

Bisphenol A alters the development of the rhesus monkey mammary gland. Proc Natl Acad Sci U S A (2012) 1.21

Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J Mammary Gland Biol Neoplasia (2013) 1.20

Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect (2010) 1.14

Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer. Biol Reprod (2011) 1.06

In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats. Environ Health (2011) 0.94

Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr Relat Cancer (2010) 0.93

A review of the carcinogenic potential of bisphenol A. Reprod Toxicol (2015) 0.92

Endocrine disruption of the epigenome: a breast cancer link. Endocr Relat Cancer (2014) 0.90

Integrated Bioinformatics, Environmental Epidemiologic and Genomic Approaches to Identify Environmental and Molecular Links between Endometriosis and Breast Cancer. Int J Mol Sci (2015) 0.88

Anthropogenic pollutants: a threat to ecosystem sustainability? Philos Trans R Soc Lond B Biol Sci (2009) 0.85

Elucidating the links between endocrine disruptors and neurodevelopment. Endocrinology (2015) 0.83

Global gene expression analysis reveals pathway differences between teratogenic and non-teratogenic exposure concentrations of bisphenol A and 17β-estradiol in embryonic zebrafish. Reprod Toxicol (2013) 0.81

Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors. Curr Med Chem (2014) 0.81

The male mammary gland: a target for the xenoestrogen bisphenol A. Reprod Toxicol (2013) 0.80

Effects of environmental pollutants on the reproduction and welfare of ruminants. Animal (2010) 0.80

Urinary bisphenol A and age at menarche among adolescent girls: evidence from NHANES 2003-2010. Environ Res (2014) 0.78

Bisphenol-A and Female Infertility: A Possible Role of Gene-Environment Interactions. Int J Environ Res Public Health (2015) 0.78

Effects of oral exposure to bisphenol A on gene expression and global genomic DNA methylation in the prostate, female mammary gland, and uterus of NCTR Sprague-Dawley rats. Food Chem Toxicol (2015) 0.76

Prenatal modulation of breast density and breast stem cells by insulin-like growth factor-1. Am J Stem Cells (2012) 0.75

Effect of bisphenol A on morphology, apoptosis and proliferation in the resting mammary gland of the adult albino rat. Int J Exp Pathol (2016) 0.75

Changes in mammary histology and transcriptome profiles by low-dose exposure to environmental phenols at critical windows of development. Environ Res (2016) 0.75

Articles by these authors

Retracted Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A (2010) 4.31

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27

Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta (2006) 2.76

Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis (2008) 2.06

The protective role of pregnancy in breast cancer. Breast Cancer Res (2005) 1.95

Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95

The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol (2006) 1.94

Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol (2005) 1.94

In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect (2010) 1.75

Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol (2003) 1.66

Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation. BMC Genomics (2008) 1.65

17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J (2006) 1.50

Development of the human breast. Maturitas (2004) 1.50

Soluble fragment of P-cadherin adhesion protein found in human milk. J Cell Biochem (2002) 1.48

Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta (2012) 1.44

Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol (2006) 1.41

ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta (2009) 1.41

Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J Immunol (2008) 1.39

Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect (2009) 1.38

MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med (2005) 1.34

Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog (2006) 1.33

Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. J Infect Dis (2006) 1.30

Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis (2007) 1.30

Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate (2007) 1.29

The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice. Cancer Epidemiol Biomarkers Prev (2003) 1.26

Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection. Blood (2008) 1.25

Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res (2007) 1.23

Breast differentiation and its implication in cancer prevention. Clin Cancer Res (2005) 1.23

Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer (2006) 1.22

Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat (2005) 1.21

Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res (2006) 1.18

Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res (2010) 1.18

A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler Thromb Vasc Biol (2013) 1.18

Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta (2009) 1.17

Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev (2008) 1.15

Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog (2007) 1.14

Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev (2006) 1.12

The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol (2005) 1.12

A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. MBio (2012) 1.11

Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia (2011) 1.11

Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol (2002) 1.11

The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci (2006) 1.08

Gene expression signatures of coronary heart disease. Arterioscler Thromb Vasc Biol (2013) 1.08

Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate (2009) 1.08

Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions. Proc Natl Acad Sci U S A (2009) 1.05

17Beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol (2002) 1.05

Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen. Int J Oncol (2007) 1.05

Genomic signature induced by pregnancy in the human breast. Int J Oncol (2006) 1.04

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci (2009) 1.04

Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates. PLoS Pathog (2013) 1.02

Power enhancement via multivariate outlier testing with gene expression arrays. Bioinformatics (2008) 1.02

Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer (2007) 1.00

Exposure to the Endocrine Disruptor Bisphenol A Alters Susceptibility for Mammary Cancer. Horm Mol Biol Clin Investig (2011) 1.00

Genotoxicity of steroidal estrogens. Trends Endocrinol Metab (2004) 1.00

17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis (2003) 1.00

Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol (2004) 0.99

Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta (2005) 0.99

Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect (2011) 0.98

Defining the genomic signature of the parous breast. BMC Med Genomics (2012) 0.97

Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause (2008) 0.97

Breast development, hormones and cancer. Adv Exp Med Biol (2008) 0.96

DR*W201/P65 tetramer visualization of epitope-specific CD4 T-cell during M. tuberculosis infection and its resting memory pool after BCG vaccination. PLoS One (2009) 0.96

Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy. J Transl Med (2010) 0.96

Prenatal TCDD exposure predisposes for mammary cancer in rats. Reprod Toxicol (2006) 0.95

TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis. J Immunol (2010) 0.94

Analysis of the functional integrity of cryopreserved human liver cells including xenografting in immunodeficient mice to address suitability for clinical applications. Liver Int (2004) 0.94

In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats. Environ Health (2011) 0.94

Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis (2002) 0.94

S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep (2006) 0.94

ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim Biophys Acta (2007) 0.93

Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett (2002) 0.93

Endocrine-active chemicals in mammary cancer causation and prevention. J Steroid Biochem Mol Biol (2011) 0.92

Re: The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst (2010) 0.92

Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP). J Nutr (2005) 0.92

Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ Mol Mutagen (2002) 0.92

Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors. Cell Oncol (2006) 0.91

NSOM- and AFM-based nanotechnology elucidates nano-structural and atomic-force features of a Y. pestis V immunogen-containing particle vaccine capable of eliciting robust response. Proteomics (2009) 0.91

DNA methylation changes in a human cell model of breast cancer progression. Mutat Res (2010) 0.91

Chemoprevention of breast cancer, proteomic discovery of genistein action in the rat mammary gland. J Nutr (2005) 0.90

Proteomic analysis in mammary glands of rat offspring exposed in utero to bisphenol A. J Proteomics (2010) 0.90

Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A (2011) 0.90

Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res (Phila) (2011) 0.89